Clinical Study

Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study

Table 7

Logistic regression model of risk factors for the metabolic syndrome. The Maracaibo City Metabolic Syndrome Prevalence Study, 2013.

Model 1*Model 2**
Crude odds ratio
(CI 95%a)
Adjusted odds ratio  (CI 95%) Adjusted odds ratioc   
(CI 95%)

Lp(a) (mg/dL)
 <18.401.001.001.00
 18.40–33.840.97 (0.76–1.24)0.820.65 (0.45–0.94)0.030.67 (0.46–0.97)0.03
 ≥33.851.73 (1.33–2.26)<0.010.76 (0.50–1.14)0.190.82 (0.54–1.23)0.33
hs-CRP (mg/L)
 <0.251.001.001.00
 0.25–0.611.18 (0.87–1.60)0.281.02 (0.72–1.44)0.931.02 (0.72–1.44)0.92
 ≥0.622.62 (1.95–3.53)<0.012.47 (1.75–3.49)<0.012.47 (1.75–3.48)<0.01
LDL-C (mg/dL)
 <100.671.001.00
 100.67–131.991.92 (1.51–2.46)<0.011.59 (1.11–2.28)0.01
 ≥132.03.24 (2.54–4.13)<0.011.81 (1.26–2.59)<0.01
Corrected LDL-C (mg/dL)
 <93.21.001.00
 93.2–123.611.75 (1.37–2.23)<0.011.51 (1.06–2.16)0.02
 ≥123.623.00 (2.36–3.81)<0.011.71 (1.20–2.43)<0.01

Confidence interval (95%). bLevel of significance.
*Adjusted by gender, ethnic group, age group, Lp(a) classification, hs-CRP tertiles, and LDL-C tertiles.
**Adjusted by gender, ethnic group, age group, Lp(a) classification, hs-CRP tertiles, and corrected LDL-C tertiles.